Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP science news

Show

From To
A tale of two trials: how adherence is everything in PrEP

Adherence makes all the difference to the efficacy of pre-exposure prophylaxis (PrEP), the 19th Conference on Retroviruses and Opportunistic Infections (CROI) heard today. Further data were presented from

Published
06 March 2012
By
Gus Cairns
PrEP needs more study before being provided, UK physicians conclude

A position statement by the British HIV Association (BHIVA) and the British Association for Sexual Health and HIV (BASHH) has concluded that as yet the data on

Published
01 March 2012
By
Gus Cairns
Australian gay men cautious about PrEP; most in need are the most interested

Only just over one in four Australian gay men in a recent scientific survey described themselves as ‘willing’ to use pre-exposure prophylaxis (PrEP) against HIV. The others,

Published
17 February 2012
By
Gus Cairns
For study participants, PrEP was an opportunity to save their relationship

Seeking to understand why adherence to pre-exposure prophylaxis (PrEP) was extremely high in a study of serodiscordant couples, qualitative researchers have found that trial participants saw PrEP

Published
30 January 2012
By
Roger Pebody
Microbicide gel fails to work in large international trial

HIV prevention researchers and campaigners reacted with disappointment today when a trial of a tenofovir-containing microbicide gel was stopped because it had not prevented any more HIV infections

Published
25 November 2011
By
Gus Cairns
High level of acceptability of PrEP among UK gay men; daily dosing preferred

While few gay men in England are currently aware of pre-exposure prophylaxis (PrEP), most men who are introduced to the idea support PrEP being made available. Half

Published
03 November 2011
By
Roger Pebody
Tenofovir PrEP arm dropped in women's HIV prevention trial

A major HIV prevention trial comparing a tenofovir microbicide with two forms of oral pre-exposure prophylaxis as HIV prevention methods for women is to halt investigation of

Published
29 September 2011
By
Keith Alcorn
'Less education' associated with PrEP and PEP use: only one in five gay men yet aware of PrEP

A survey (Mansergh) of 454 HIV-negative gay men in four US cities (New York, Los Angeles, Chicago and San Francisco) has found that men with lower educational attainment

Published
16 September 2011
By
Gus Cairns
High levels of PrEP efficacy demanded by gay men before they consider it a replacement for condoms

PrEP would need to provide near perfect levels of protection against infection with HIV in order for the majority of gay men to see it as

Published
10 August 2011
By
Michael Carter
PrEP acceptable to gay men and few report that it would change their risk behaviour

Approximately 50% of American gay men said they were likely to use pre-exposure prophylaxis (PrEP), but few reported that it would lead to a change in their

Published
10 August 2011
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.